Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2011 1
2012 1
2013 2
2014 1
2015 1
2017 2
2018 2
2020 1
2021 2
2022 2
2023 3
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

18 results

Results by year

Filters applied: . Clear all
Page 1
[Overwiew of compounding oncology pharmacy in France in 2021].
Devys C, Desmaris R, Cormier N. Devys C, et al. Among authors: desmaris r. Ann Pharm Fr. 2024 Feb 8:S0003-4509(24)00009-9. doi: 10.1016/j.pharma.2024.02.004. Online ahead of print. Ann Pharm Fr. 2024. PMID: 38340804 Review. French.
Reporting environmental contamination results to healthcare workers could play a crucial role in decreasing the risk of occupational exposure to antineoplastic drugs.
Acramel A, Blondeel-Gomes S, Matta C, Narayani S, Madar O, Desmaris R, Escalup L, Fouque J. Acramel A, et al. Among authors: desmaris r. Front Public Health. 2022 Aug 25;10:989977. doi: 10.3389/fpubh.2022.989977. eCollection 2022. Front Public Health. 2022. PMID: 36091516 Free PMC article. No abstract available.
High incidence of cetuximab-related infusion reactions in head and neck patients.
Palomar Coloma V, Bravo P, Lezghed N, Mayache-Badis L, Herrera Gómez RG, Iacob M, Nicouleau L, Desmaris R, Tao Y, Leibu C, Matias M, Lemare F, Even C, Annereau M, Ferté C. Palomar Coloma V, et al. Among authors: desmaris r. ESMO Open. 2018 Jul 23;3(5):e000346. doi: 10.1136/esmoopen-2018-000346. eCollection 2018. ESMO Open. 2018. PMID: 30094066 Free PMC article.
Attenuated cytarabine, etoposide, dexamethasone plus rituximab (R-Mini-CYVE) regimen for patients with relapsed or refractory B-cell non-Hodgkin's lymphoma not eligible for intensive chemotherapy.
Abdayem P, Ibrahim N, El Dakdouki Y, Willekens C, Ghez D, A Rouche J, Dartigues P, Desmaris R, Danu A, Rossignol J, Lazarovici J, Fermé C, Ribrag V, Michot JM. Abdayem P, et al. Among authors: desmaris r. Eur J Haematol. 2021 Apr;106(4):574-583. doi: 10.1111/ejh.13589. Epub 2021 Feb 4. Eur J Haematol. 2021. PMID: 33512026
Use of 5-azacitidine for therapy-related myeloid neoplasms in patients with concomitant active neoplastic disease.
Annereau M, Willekens C, El Halabi L, Chahine C, Saada V, Auger N, Danu A, Bermudez E, Lazarovici J, Ghez D, Leary A, Pistilli B, Lemare F, Solary E, de Botton S, Desmaris RP, Micol JB. Annereau M, et al. Among authors: desmaris rp. Leuk Res. 2017 Apr;55:58-64. doi: 10.1016/j.leukres.2017.01.024. Epub 2017 Jan 20. Leuk Res. 2017. PMID: 28131982
Advanced prescription of injectable anticancer drugs: Safety assessment in a European Comprehensive Cancer Centre using the risk matrix approach.
Acramel A, Blondeel-Gomes S, Dupré M, Kayembe OT, Rochereau A, Escalup L, Desmaris R, Jourdan N, Cordary A, Vaflard P, Cottu P, Bellesoeur A. Acramel A, et al. Among authors: desmaris r. Br J Clin Pharmacol. 2024 Feb 25. doi: 10.1111/bcp.16020. Online ahead of print. Br J Clin Pharmacol. 2024. PMID: 38403473
18 results